Article Information
History
- April 20, 2021.
Article Versions
- You are currently viewing Version 1 of this article (April 20, 2021 - 08:49).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Stefania L Calvisi1,§,
- Giuseppe A Ramirez2,3,§,
- Marina Scavini4,
- Valentina Da Prat1,
- Giuseppe Di Lucca1,
- Andrea Laurenzi4,5,
- Gabriele Gallina1,3,
- Ludovica Cavallo1,3,
- Giorgia Borio1,3,
- Federica Farolfi1,3,
- Maria Pascali1,3,
- Jacopo Castellani1,3,
- Vito Lampasona4,
- Armando D’Angelo3,6,
- Giovanni Landoni3,7,
- Fabio Ciceri3,7,
- Patrizia Rovere Querini3,5,
- Moreno Tresoldi1,* and
- Lorenzo Piemonti3,4,*,#
- 1Unit of General Medicine and Advanced Care, IRCCS Ospedale San Raffaele, Milan, Italy
- 2Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 3Università Vita-Salute San Raffaele, Milan, Italy
- 4Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- 5Unit of Internal Medicine and Endocrinology, IRCCS Ospedale San Raffaele, Milan, Italy
- 6Coagulation service and Thrombosis Research Unit, IRCCS Ospedale San Raffaele, Milan, Italy
- 7Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 8Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, Milan, Italy
- ↵#Correspondence to:
Lorenzo Piemonti, Diabetes Research Institute, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy. Tel: 39 02 26432706, Fax: 39 02 26432871, E-mail: piemonti.lorenzo{at}hsr.it
Posted April 20, 2021.
Thromboembolism risk is higher among patients with diabetes and COVID-19 and is associated to poor clinical outcome
